Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials
Authors
Keywords
-
Journal
HYPERTENSION RESEARCH
Volume 36, Issue 4, Pages 368-373
Publisher
Springer Nature
Online
2012-12-13
DOI
10.1038/hr.2012.196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of telmisartan on C-reactive protein levels: A meta-analysis of randomized controlled trials
- (2012) Hisato Takagi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Changes in Urinary Albumin Excretion, Inflammatory and Oxidative Stress Markers in ADPKD Patients with Hypertension
- (2011) Tsukasa Nakamura et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Telmisartan reduces neointima volume and pulse wave velocity 8 months after zotarolimus-eluting stent implantation in hypertensive type 2 diabetic patients
- (2011) S. J. Hong et al. HEART
- High-Dose Treatment With Telmisartan Induces Monocytic Peroxisome Proliferator-Activated Receptor-γ Target Genes in Patients With the Metabolic Syndrome
- (2011) Ilse-Nirmala Bähr et al. HYPERTENSION
- Telmisartan increases adiponectin levels: A meta-analysis and meta-regression of randomized head-to-head trials
- (2011) Hisato Takagi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment
- (2010) Christian Cadeddu et al. AMERICAN HEART JOURNAL
- Effect of telmisartan on selected adipokines, insulin sensitivity, and substrate utilization during insulin-stimulated conditions in patients with metabolic syndrome and impaired fasting glucose
- (2010) Petr Wohl et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Systematic review and meta-analysis: Anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis
- (2010) Cheryl Barnabe et al. ARTHRITIS CARE & RESEARCH
- Inhibition of Tumor Necrosis Factor-α–Induced Interleukin-6 Expression by Telmisartan Through Cross-Talk of Peroxisome Proliferator-Activated Receptor-γ With Nuclear Factor κB and CCAAT/Enhancer-Binding Protein-β
- (2009) Qingping Tian et al. HYPERTENSION
- Inflammatory Markers and Poor Outcome after Stroke: A Prospective Cohort Study and Systematic Review of Interleukin-6
- (2009) William Whiteley et al. PLOS MEDICINE
- Comparison of Renal and Vascular Protective Effects between Telmisartan and Amlodipine in Hypertensive Patients with Chronic Kidney Disease with Mild Renal Insufficiency
- (2008) Tsukasa NAKAMURA et al. HYPERTENSION RESEARCH
- Comparison of Effects of Olmesartan and Telmisartan on Blood Pressure and Metabolic Parameters in Japanese Early-Stage Type-2 Diabetics with Hypertension
- (2008) Shiho NAKAYAMA et al. HYPERTENSION RESEARCH
- Pioglitazone reduces tumor necrosis factor-α serum concentration and mRNA expression of adipose tissue in hypercholesterolemic rabbits
- (2008) Zhi-hong Wu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review
- (2008) John Danesh et al. PLOS MEDICINE
- The effect of thiazolidinediones on adiponectin serum level: a meta-analysis
- (2007) N. Riera-Guardia et al. DIABETES OBESITY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search